Appraising cervical mucus: a new approach to evaluating contraceptives
Purpose: Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement...
Saved in:
| Published in | The European journal of contraception & reproductive health care Vol. 23; no. 1; pp. 78 - 83 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Taylor & Francis
01.02.2018
Taylor & Francis Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Purpose: Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement in ovarian suppressed women.
Materials and methods: We conducted a prospective experiment (clinicaltrials.gov, NCT02969590) examining cervical mucus changes in six women during natural and artificial menstrual cycles [leuprolide acetate, estradiol transdermal patch (0.05-0.3 mg/day) and progesterone 200 mg/day]. We collected serum and mucus samples at each visit corresponding to early, mid and late follicular, ovulation and mid-luteal time points in the natural and artificial cycles. We evaluated mucus according to the modified Insler score described in the WHO laboratory Manual for the Examination and Processing of Human Semen.
Results: We enrolled healthy women between 27 and 40 years of age. All of the subjects achieved a mucus score of ≥10 both in the natural cycle and during peak estradiol replacement levels (0.3 mg/day) in the artificial cycle. During the simulated luteal phase, all mucus scores were ≤5 (median 3.5; range 1-5), similar to scores seen in the luteal phase of natural cycles (median 1; range 1-3).
Conclusions: Our artificial cycle model (leuprolide acetate suppression) and dose escalation with estradiol patches produced favourable cervical mucus with mucus scores similar to those in the periovulatory phase of natural menstrual cycles. Additional studies are needed to validate the model for evaluation of mucus effects of contraceptive agents. |
|---|---|
| AbstractList | Purpose: Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement in ovarian suppressed women.
Materials and methods: We conducted a prospective experiment (clinicaltrials.gov, NCT02969590) examining cervical mucus changes in six women during natural and artificial menstrual cycles [leuprolide acetate, estradiol transdermal patch (0.05-0.3 mg/day) and progesterone 200 mg/day]. We collected serum and mucus samples at each visit corresponding to early, mid and late follicular, ovulation and mid-luteal time points in the natural and artificial cycles. We evaluated mucus according to the modified Insler score described in the WHO laboratory Manual for the Examination and Processing of Human Semen.
Results: We enrolled healthy women between 27 and 40 years of age. All of the subjects achieved a mucus score of ≥10 both in the natural cycle and during peak estradiol replacement levels (0.3 mg/day) in the artificial cycle. During the simulated luteal phase, all mucus scores were ≤5 (median 3.5; range 1-5), similar to scores seen in the luteal phase of natural cycles (median 1; range 1-3).
Conclusions: Our artificial cycle model (leuprolide acetate suppression) and dose escalation with estradiol patches produced favourable cervical mucus with mucus scores similar to those in the periovulatory phase of natural menstrual cycles. Additional studies are needed to validate the model for evaluation of mucus effects of contraceptive agents. Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement in ovarian suppressed women. We conducted a prospective experiment (clinicaltrials.gov, NCT02969590) examining cervical mucus changes in six women during natural and artificial menstrual cycles [leuprolide acetate, estradiol transdermal patch (0.05-0.3 mg/day) and progesterone 200 mg/day]. We collected serum and mucus samples at each visit corresponding to early, mid and late follicular, ovulation and mid-luteal time points in the natural and artificial cycles. We evaluated mucus according to the modified Insler score described in the WHO laboratory Manual for the Examination and Processing of Human Semen. We enrolled healthy women between 27 and 40 years of age. All of the subjects achieved a mucus score of ≥10 both in the natural cycle and during peak estradiol replacement levels (0.3 mg/day) in the artificial cycle. During the simulated luteal phase, all mucus scores were ≤5 (median 3.5; range 1-5), similar to scores seen in the luteal phase of natural cycles (median 1; range 1-3). Our artificial cycle model (leuprolide acetate suppression) and dose escalation with estradiol patches produced favourable cervical mucus with mucus scores similar to those in the periovulatory phase of natural menstrual cycles. Additional studies are needed to validate the model for evaluation of mucus effects of contraceptive agents. Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement in ovarian suppressed women.PURPOSETiming of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement in ovarian suppressed women.We conducted a prospective experiment (clinicaltrials.gov, NCT02969590) examining cervical mucus changes in six women during natural and artificial menstrual cycles [leuprolide acetate, estradiol transdermal patch (0.05-0.3 mg/day) and progesterone 200 mg/day]. We collected serum and mucus samples at each visit corresponding to early, mid and late follicular, ovulation and mid-luteal time points in the natural and artificial cycles. We evaluated mucus according to the modified Insler score described in the WHO laboratory Manual for the Examination and Processing of Human Semen.MATERIALS AND METHODSWe conducted a prospective experiment (clinicaltrials.gov, NCT02969590) examining cervical mucus changes in six women during natural and artificial menstrual cycles [leuprolide acetate, estradiol transdermal patch (0.05-0.3 mg/day) and progesterone 200 mg/day]. We collected serum and mucus samples at each visit corresponding to early, mid and late follicular, ovulation and mid-luteal time points in the natural and artificial cycles. We evaluated mucus according to the modified Insler score described in the WHO laboratory Manual for the Examination and Processing of Human Semen.We enrolled healthy women between 27 and 40 years of age. All of the subjects achieved a mucus score of ≥10 both in the natural cycle and during peak estradiol replacement levels (0.3 mg/day) in the artificial cycle. During the simulated luteal phase, all mucus scores were ≤5 (median 3.5; range 1-5), similar to scores seen in the luteal phase of natural cycles (median 1; range 1-3).RESULTSWe enrolled healthy women between 27 and 40 years of age. All of the subjects achieved a mucus score of ≥10 both in the natural cycle and during peak estradiol replacement levels (0.3 mg/day) in the artificial cycle. During the simulated luteal phase, all mucus scores were ≤5 (median 3.5; range 1-5), similar to scores seen in the luteal phase of natural cycles (median 1; range 1-3).Our artificial cycle model (leuprolide acetate suppression) and dose escalation with estradiol patches produced favourable cervical mucus with mucus scores similar to those in the periovulatory phase of natural menstrual cycles. Additional studies are needed to validate the model for evaluation of mucus effects of contraceptive agents.CONCLUSIONSOur artificial cycle model (leuprolide acetate suppression) and dose escalation with estradiol patches produced favourable cervical mucus with mucus scores similar to those in the periovulatory phase of natural menstrual cycles. Additional studies are needed to validate the model for evaluation of mucus effects of contraceptive agents. Purpose: Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in naturally-cycling women. We sought to create and validate an artificial model of the cervical mucus cycle using exogenous E2 and P4 replacement in ovarian suppressed women.Materials and methods: We conducted a prospective experiment (clinicaltrials.gov, NCT02969590) examining cervical mucus changes in six women during natural and artificial menstrual cycles [leuprolide acetate, estradiol transdermal patch (0.05–0.3 mg/day) and progesterone 200 mg/day]. We collected serum and mucus samples at each visit corresponding to early, mid and late follicular, ovulation and mid-luteal time points in the natural and artificial cycles. We evaluated mucus according to the modified Insler score described in the WHO laboratory Manual for the Examination and Processing of Human Semen.Results: We enrolled healthy women between 27 and 40 years of age. All of the subjects achieved a mucus score of ≥10 both in the natural cycle and during peak estradiol replacement levels (0.3 mg/day) in the artificial cycle. During the simulated luteal phase, all mucus scores were ≤5 (median 3.5; range 1–5), similar to scores seen in the luteal phase of natural cycles (median 1; range 1–3).Conclusions: Our artificial cycle model (leuprolide acetate suppression) and dose escalation with estradiol patches produced favourable cervical mucus with mucus scores similar to those in the periovulatory phase of natural menstrual cycles. Additional studies are needed to validate the model for evaluation of mucus effects of contraceptive agents. |
| Author | Edelman, Alison Padua, Emily Jensen, Jeffrey T. Han, Leo |
| Author_xml | – sequence: 1 givenname: Leo orcidid: 0000-0003-2018-6028 surname: Han fullname: Han, Leo email: hanl@ohsu.edu organization: Department of Obstetrics and Gynecology, Oregon Health & Science University – sequence: 2 givenname: Emily surname: Padua fullname: Padua, Emily organization: Department of Obstetrics and Gynecology, Oregon Health & Science University – sequence: 3 givenname: Alison surname: Edelman fullname: Edelman, Alison organization: Department of Obstetrics and Gynecology, Oregon Health & Science University – sequence: 4 givenname: Jeffrey T. surname: Jensen fullname: Jensen, Jeffrey T. organization: Department of Obstetrics and Gynecology, Oregon Health & Science University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29457758$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtv2zAQhInARWIn-QktBPTSi1w-Ram91AjyKBCgl-RMrNZUy0AiXVJykH8fOrYvObQn7uGb4e7Mgsx88JaQj4wuGa3pVyYqrlitl5yyesmk0EzIEzJnUouS6prP8pyZcgedkUVKT5RmRFSn5Iw3Ummt6jm5WW02EVxy_neBNm4dQl8ME07pWwGFt88FZCAA_inGUNgt9BOMb3DwYwS0m9FtbbogHzrok708vOfk8eb64equvP91-_NqdV-iaORYKqSKda1E7ETT2vUaOaWqQSWkZE2LoFSlW4624ZAhrQBFhbyrRNW2rRTinHzZ--ad_k42jWZwCW3fg7dhSibbSVlR0bCMfn6HPoUp-rydEbTWORbKeaY-HaipHezabKIbIL6YY0IZ-L4HMIaUou0MujFH8Ha-6w2jZteHOfZhdn2YQx9Zrd6pjx_8T_djr3O-C3GA5xD7tRnhpQ-xi-DR5Sv-bfEKo1WgSA |
| CitedBy_id | crossref_primary_10_1016_j_contraception_2022_03_016 crossref_primary_10_1016_j_xfss_2023_03_002 crossref_primary_10_1080_13625187_2019_1605503 crossref_primary_10_1371_journal_pone_0304552 crossref_primary_10_1002_prca_202100023 crossref_primary_10_1039_C8CS00948A crossref_primary_10_1093_biolre_ioae121 |
| Cites_doi | 10.1016/S0002-9378(97)70520-9 10.1016/S0015-0282(16)38467-9 10.1016/S0015-0282(97)00476-7 10.1136/bmj.2.5554.730 10.1016/j.contraception.2012.09.034 10.1093/humupd/6.2.139 10.1016/S0015-0282(16)41835-2 10.1016/S0015-0282(16)38342-X 10.1136/bmj.2.5659.730 10.1016/j.contraception.2017.07.168 10.2165/00003088-199018060-00004 10.1016/S0015-0282(16)43454-0 10.1210/jc.2008-0460 10.1093/humrep/10.1.85 10.1016/S0010-7824(96)00191-6 10.1016/S0015-0282(16)60497-1 10.1016/S0015-0282(16)53171-9 10.1111/j.1471-0528.1970.tb03409.x 10.1515/CCLM.2006.160 10.1016/0010-7824(91)90135-3 10.1016/S0002-9378(99)70120-1 10.1093/humrep/deg209 10.1016/S0015-0282(97)00477-9 10.1210/jcem-69-4-804 10.1016/j.contraception.2016.03.006 10.1016/j.fertnstert.2013.07.911 10.1016/S0015-0282(16)46095-4 10.1161/HYPERTENSIONAHA.110.163386 10.1016/0002-9378(72)90617-5 10.1016/S0015-0282(16)43035-9 10.1016/S0015-0282(16)37083-2 |
| ContentType | Journal Article |
| Copyright | 2018 The European Society of Contraception and Reproductive Health 2018 2018 The European Society of Contraception and Reproductive Health |
| Copyright_xml | – notice: 2018 The European Society of Contraception and Reproductive Health 2018 – notice: 2018 The European Society of Contraception and Reproductive Health |
| DBID | AAYXX CITATION NPM K9. 7X8 |
| DOI | 10.1080/13625187.2018.1437134 |
| DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1473-0782 |
| EndPage | 83 |
| ExternalDocumentID | 29457758 10_1080_13625187_2018_1437134 1437134 |
| Genre | Research Article Journal Article |
| GroupedDBID | --- 00X 03L 0BK 0R~ 123 29G 36B 4.4 6PF AALUX AAMIU AAPUL AAQRR AAWTL ABBKH ABDBF ABEIZ ABIVO ABJNI ABLIJ ABLKL ABUPF ABXYU ACENM ACGEJ ACGFS ACIEZ ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AGDLA AGFJD AGRBW AGYJP AHMBA AIJEM AIRBT AJWEG AKBVH ALIPV ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EAS EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM M4Z O9- RNANH RRB RVRKI RWL SV3 TAE TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS V1S ~1N AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION 53G 5VS 7X7 88E 8AO 8FI 8FJ 8G5 AALIY AAORF AAPXX ABUWG ABWCV ABZEW ACKZS ACOPL ADBBV ADFOM ADFZZ AEIIZ AFKRA AFLEI AJVHN AWYRJ AZQEC BENPR BPHCQ BRMBE BVXVI CAG CCPQU COF CYYVM CZDIS DRXRE DWQXO DWTOO FYUFA GNUQQ GUQSH HMCUK JENTW LJTGL M1P M2O M44 NPM NUSFT PADUT PHGZT PQQKQ PROAC PSQYO QQXMO S0X UKHRP K9. TASJS 7X8 |
| ID | FETCH-LOGICAL-c394t-5c051fb4ccf39beddc20059c534419bca5567b2ce92a4cc75ac36c2f636bbb433 |
| ISSN | 1362-5187 1473-0782 |
| IngestDate | Tue Aug 05 11:38:12 EDT 2025 Sat Jul 26 02:41:50 EDT 2025 Thu Apr 03 06:59:22 EDT 2025 Tue Jul 01 04:00:29 EDT 2025 Thu Apr 24 23:10:08 EDT 2025 Wed Dec 25 09:04:54 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Cervical mucus model insler contraception |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c394t-5c051fb4ccf39beddc20059c534419bca5567b2ce92a4cc75ac36c2f636bbb433 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0003-2018-6028 |
| PMID | 29457758 |
| PQID | 3087518022 |
| PQPubID | 44424 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_2004460391 informaworld_taylorfrancis_310_1080_13625187_2018_1437134 pubmed_primary_29457758 crossref_citationtrail_10_1080_13625187_2018_1437134 crossref_primary_10_1080_13625187_2018_1437134 proquest_journals_3087518022 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-Feb |
| PublicationDateYYYYMMDD | 2018-02-01 |
| PublicationDate_xml | – month: 02 year: 2018 text: 2018-Feb |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Carnforth |
| PublicationTitle | The European journal of contraception & reproductive health care |
| PublicationTitleAlternate | Eur J Contracept Reprod Health Care |
| PublicationYear | 2018 |
| Publisher | Taylor & Francis Taylor & Francis Ltd |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Ltd |
| References | CIT0030 CIT0010 CIT0032 CIT0012 CIT0011 CIT0033 CIT0014 CIT0036 CIT0013 CIT0035 CIT0038 CIT0015 CIT0037 CIT0018 Cox HJ. (CIT0034) 1968; 6 CIT0017 CIT0039 Moghissi KS (CIT0004) 1973; 41 CIT0019 Slayden OD (CIT0031) 2001; 86 CIT0040 CIT0021 CIT0020 CIT0001 Lebech PE (CIT0016) 1970; 15 CIT0023 CIT0022 CIT0003 CIT0025 CIT0002 CIT0024 CIT0005 CIT0027 CIT0026 CIT0007 CIT0029 CIT0006 CIT0028 CIT0009 CIT0008 |
| References_xml | – ident: CIT0026 doi: 10.1016/S0002-9378(97)70520-9 – ident: CIT0006 doi: 10.1016/S0015-0282(16)38467-9 – ident: CIT0012 doi: 10.1016/S0015-0282(97)00476-7 – ident: CIT0009 doi: 10.1136/bmj.2.5554.730 – volume: 6 start-page: 167 year: 1968 ident: CIT0034 publication-title: J Reprod Fertil Suppl – ident: CIT0011 doi: 10.1016/j.contraception.2012.09.034 – ident: CIT0027 doi: 10.1093/humupd/6.2.139 – ident: CIT0036 doi: 10.1016/S0015-0282(16)41835-2 – ident: CIT0017 doi: 10.1016/S0015-0282(16)38342-X – ident: CIT0007 doi: 10.1136/bmj.2.5659.730 – ident: CIT0002 – ident: CIT0013 doi: 10.1016/j.contraception.2017.07.168 – ident: CIT0033 doi: 10.2165/00003088-199018060-00004 – ident: CIT0015 doi: 10.1016/S0015-0282(16)43454-0 – ident: CIT0024 doi: 10.1210/jc.2008-0460 – ident: CIT0038 doi: 10.1093/humrep/10.1.85 – ident: CIT0018 doi: 10.1016/S0010-7824(96)00191-6 – ident: CIT0039 doi: 10.1016/S0015-0282(16)60497-1 – ident: CIT0040 doi: 10.1016/S0015-0282(16)53171-9 – ident: CIT0005 doi: 10.1111/j.1471-0528.1970.tb03409.x – ident: CIT0022 doi: 10.1515/CCLM.2006.160 – ident: CIT0020 – volume: 15 start-page: 65 year: 1970 ident: CIT0016 publication-title: Int J Fertil – volume: 86 start-page: 2668 year: 2001 ident: CIT0031 publication-title: J Clin Endocrinol Metab – ident: CIT0019 doi: 10.1016/0010-7824(91)90135-3 – ident: CIT0003 doi: 10.1016/S0002-9378(99)70120-1 – ident: CIT0037 doi: 10.1093/humrep/deg209 – volume: 41 start-page: 585 year: 1973 ident: CIT0004 publication-title: Obstet Gynecol – ident: CIT0010 doi: 10.1016/S0015-0282(97)00477-9 – ident: CIT0028 – ident: CIT0001 – ident: CIT0023 doi: 10.1210/jcem-69-4-804 – ident: CIT0029 doi: 10.1016/j.contraception.2016.03.006 – ident: CIT0032 – ident: CIT0030 doi: 10.1016/j.fertnstert.2013.07.911 – ident: CIT0025 doi: 10.1016/S0015-0282(16)46095-4 – ident: CIT0021 doi: 10.1161/HYPERTENSIONAHA.110.163386 – ident: CIT0014 doi: 10.1016/0002-9378(72)90617-5 – ident: CIT0035 doi: 10.1016/S0015-0282(16)43035-9 – ident: CIT0008 doi: 10.1016/S0015-0282(16)37083-2 |
| SSID | ssj0013436 |
| Score | 2.1783683 |
| Snippet | Purpose: Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in... Timing of sample collection represents a major source of variability in studies evaluating the effects of administered agents on cervical mucus in... |
| SourceID | proquest pubmed crossref informaworld |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 78 |
| SubjectTerms | Birth control Cervical mucus contraception insler Menstruation |
| Title | Appraising cervical mucus: a new approach to evaluating contraceptives |
| URI | https://www.tandfonline.com/doi/abs/10.1080/13625187.2018.1437134 https://www.ncbi.nlm.nih.gov/pubmed/29457758 https://www.proquest.com/docview/3087518022 https://www.proquest.com/docview/2004460391 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWVkJcEG-2FBQkrikktpM1ty3tanm0QmIr9RbFj0hFqyxqkx74L_xXZvzIQywUuESrZB1Hns_j8Xi-GUJeqdQIzWUSVzPBYsbLBOYc1TFYD1WpDCwoFPnOJ6fZ8ox9OOfnk8mPQdRS28gD9X0rr-R_pAr3QK7Ikv0HyXYvhRvwG-QLV5AwXP9KxmBCXpYXjjdr5zxSQVrVXjkKM1jMXc5wtDFDZm9Ls0Wnrg1pufZRhF973Ixc9N5cHbTwgMF8mDZdLAYfOT6lTXTdKzVHazCb_pxKt9ZYPUavSmfMa7P2ftj5GoObuqgeU3v_kOeb-Yhu76RIZiGu2cNq9Uu9kEHQEqpd5G7xxC-9xt1jOY3RgBnqasdNHmHSKV5XBygs4XTr4uCiKbEv7ArD-mawUFBk0_arYYgAWM6_FJ-PFsWn96cfb5HdFHYhoEZ354dHh4v-mIrZGpTd5weK2OzN663djIyfUWrc329wrKGzukfu-h1KNHdwu08mpn5Abp_4GIyHZNGjLgqoiyzq3kZlBJiLAuaiZhP1mIvGmHtEzhbHq3fL2FfjiBUVrIm5Av1dSaZURYU0Wit0SArFKVjUQqqS8yyXqTIiLeFPOS8VzVRaZTSTUjJKH5OdelObpyRKQDlwmadZqhUDA1FUmCJTp1pneQbDNiUsDFOhfKp6rJiyLhKf0TaMboGjW_jRnZKDrtk3l6vlpgZiKIOisTCtHEILekPb_SCwwk9GaIL1ITCnYjolL7vHoLDxFK6szaa9wrqvjGVYmGFKnjhBd1-bCsZz2MHv_fnlz8idfpLtk53msjXPwTZu5AuP0J88KbM- |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Appraising+cervical+mucus%3A+a+new+approach+to+evaluating+contraceptives&rft.jtitle=The+European+journal+of+contraception+%26+reproductive+health+care&rft.au=Han%2C+Leo&rft.au=Padua%2C+Emily&rft.au=Edelman%2C+Alison&rft.au=Jensen%2C+Jeffrey+T&rft.date=2018-02-01&rft.pub=Taylor+%26+Francis+Ltd&rft.issn=1362-5187&rft.eissn=1473-0782&rft.volume=23&rft.issue=1&rft.spage=78&rft.epage=83&rft_id=info:doi/10.1080%2F13625187.2018.1437134&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1362-5187&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1362-5187&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1362-5187&client=summon |